CC(C)(C)OC(=O)N1CCCC1C(=O)NCCNc1ccc(NCCNC(=O)C2CCCN2C(=O)OC(C)(C)C)c2c1C(=O)c1ccccc1C2=O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?